Cargando…
Risk of tuberculosis in patients with rheumatoid arthritis treated with biological and targeted drugs: meta-analysis of randomized clinical trials
BACKGROUND: Concerns exist regarding the potential development of tuberculosis in patients with rheumatoid arthritis (RA) treated with biological and targeted drugs. We assessed systematically whether biological therapy increased the risk of tuberculosis in patients with RA by meta-analysis of rando...
Autores principales: | Ji, Xiaojian, Hu, Lidong, Wang, Yiwen, Man, Siliang, Liu, Xingkang, Song, Chuan, Zhang, Jiaxin, Zhu, Jian, Zhang, Jianglin, Huang, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869575/ https://www.ncbi.nlm.nih.gov/pubmed/35194004 http://dx.doi.org/10.1097/CM9.0000000000001948 |
Ejemplares similares
-
Risk of infections of biological and targeted drugs in patients with spondyloarthritis: meta-analysis of randomized clinical trials
por: Hu, Lidong, et al.
Publicado: (2022) -
Comparative efficacy and safety of Janus kinase inhibitors and biological disease-modifying antirheumatic drugs in rheumatoid arthritis: a systematic review and network meta-analysis
por: Weng, Chenghua, et al.
Publicado: (2021) -
Diagnostic value of anti-cyclic citrullinated peptide antibody combined with rheumatoid factor in rheumatoid arthritis in Asia: a meta-analysis
por: Yang, Xiaochun, et al.
Publicado: (2021) -
The prevalence of depression in rheumatoid arthritis in China: A systematic review
por: Fu, Xin, et al.
Publicado: (2017) -
Underweight and obesity are strong predictors of clinical outcomes in
patients with ankylosing spondylitis: data from the Smart-phone
SpondyloArthritis Management System
por: Hu, Lidong, et al.
Publicado: (2021)